Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: What it tells us about the condition and what it means for future studies

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 11, 2010, Pages 2730-2734

  Allen, Matthew R ^a   Pandya, Binal ^a   Ruggiero, Salvatore L ^b,c  

^a INDIANA UNIVERSITY   (United States)

^b New York Center for Orthognathic and Maxillary Surgery   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE TISSUE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOLOGY; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; JAW; JAW DISEASES; MALE; MIDDLE AGED; ORGAN SIZE; OSTEONECROSIS; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 78049291848     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2010.05.090     Document Type: Article

References (13)

1. R.G. Russell, Z. Xia, and J.E. Dunford Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy Ann N Y Acad Sci 1117 2007 209
2. G.A. Rodan, and H.A. Fleisch Bisphosphonates: Mechanisms of action J Clin Invest 97 1996 2692
3. M.R. Allen, and D.B. Burr The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data J Oral Maxillofac Surg 67 2009 61
4. S. Khosla, D. Burr, and J. Cauley Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479
5. P. Lesclous, S. Abi Najm, and J.P. Carrel Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation? Bone 45 2009 843
6. P.P. Sedghizadeh, S.K. Kumar, and A. Gorur Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy J Oral Maxillofac Surg 66 2008 767
7. P.P. Sedghizadeh, S.K. Kumar, and A. Gorur Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy J Am Dent Assoc 140 2009 1259
8. M.R. Allen, and S.L. Ruggiero Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw J Oral Maxillofac Surg 67 2009 1373
9. A. Badros, D. Weikel, and A. Salama Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors J Clin Oncol 24 2006 945
10. A. Bedogni, S. Blandamura, and Z. Lokmic Bisphosphonate-associated jawbone osteonecrosis: A correlation between imaging techniques and histopathology Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 105 2008 358
11. G. Favia, G.P. Pilolli, and E. Maiorano Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy Bone 45 2009 406
12. A. Allegra, S. Russo, and A. Cannavo Immunohistochemical evaluation of sarcoglycan and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the JAW Haematologica 94 2009 0943
13. A.O. Hoff, B.B. Toth, and K. Altundag Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826